最新ニュース Xos (NASDAQ:XOS) 株価情報

XOS INC

Xos Inc is an electric mobility company. It designs and develops fully electric battery mobility systems specifically for commercial fleets. The company's primary focus is on medium- and heavy-duty commercial vehicles that travel on last mile routes. The company leverages its proprietary technologies to provide commercial fleets zero emission vehicles that are easier to maintain and more cost-efficient on a total cost of ownership basis than internal combustion engine and commercial EV counterparts.

Xos Inc

William Blair analyst Dylan Carden initiates coverage on Savers Value Village (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SVV#NYSE">SVV</a>) with a Outperform rating.

News

Initiation

Analyst Ratings

William Blair Initiates Coverage On Savers Value Village with Outperform Rating

Baird analyst Craig Kennison downgrades RumbleON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>) from Outperform to Neutral and lowers the price target from $5 to $3.

Downgrades

Price Target

RMBL

Baird Downgrades RumbleON to Neutral, Lowers Price Target to $3

<a href="https://img1.wsimg.com/blobby/go/cc91fda7-4669-4d1b-81ce-a0b8d77f25ab/downloads/c7d21803-e1e5-4a88-8740-7465b3f25ad0/Culper_GRRR_4-4-2025.pdf?ver=1743770140803" title="https://img1.wsimg.com/blobby/go/cc91fda7-4669-4d1b-81ce-a0b8d77f25ab/downloads/c7d21803-e1e5-4a88-8740-7465b3f25ad0/Culper_GRRR_4-4-2025.pdf?ver=1743770140803">https://img1.wsimg.com/blobby/go/cc91fda7-4669-4d1b-81ce-a0b8d77f25ab/downloads/c7d21803-e1e5-4a88-8740-7465b3f25ad0/Culper_GRRR_4-4-2025.pdf?ver=1743770140803</a>

Short Sellers

Trading Ideas

GRRR

Watching Gorilla Technology; Culper Research Issues Short Report On Co

Baird analyst Craig Kennison downgrades Patrick Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PATK#NASDAQ">PATK</a>) from Outperform to Neutral and lowers the price target from $100 to $96.

PATK

Baird Downgrades Patrick Industries to Neutral, Lowers Price Target to $96

Citigroup analyst Spiro Dounis initiates coverage on Enbridge (CSE2: ENB) with a Buy rating and announces Price Target of C$75.

Citigroup Initiates Coverage On Enbridge with Buy Rating, Announces Price Target of C$75

<a href="https://www.globenewswire.com/Tracker?data=VxHo1_SeeSOuaURybab7ked29qE8ezMZodvTjLAvq_Kg9d4AUSOr1SJKUM6OgiyjgYMu4e1R2PjJUryKu50XfXQfoqDwRZvsqzAUQY0B8Ie44KmsQdo8EJ8ee99tsoG_uCWOsd9ebAUapgCgfmYxHg==">American Battery Technology Company&nbsp;</a>(ABTC) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABAT#NASDAQ">ABAT</a>), an integrated critical battery materials company that is commercializing its technologies for both primary battery minerals manufacturing and secondary minerals lithium-ion battery recycling, has announced the sale of one of its unused legacy properties located at 395 Logan Lane in Fernley, Nevada. This 12-acre property entered into contract to sell for $6.75 million, with the transaction expected to close on or before July 10, 2025. &nbsp;
This strategic sale will support the company's mission to advance its lithium-ion battery recycling technologies and streamlined operations at its commercial-scale battery recycling facility in the Tahoe-Reno Industrial Center (TRIC) at 2500 Peru Drive, McCarran, Nevada. The prioritization of this operational facility at TRIC allows ABTC to continue its focused implementation on its innovative recycling processes that are critical to developing a domestic supply of refined battery materials.

Contracts

Asset Sales

ABAT

American Battery Technology Announces $6.75M Sale Of Legacy Property In Fernley, Nevada, To Support Advancements In Lithium-Ion Battery Recycling And Operations At TRIC Facility

As Wall Street crumbles from the impact of tariffs, cracks are still not visible in the U.S. labor market, which continues to show resilience and defies investor <a href="https://www.benzinga.com/news/econ-s">fears of economic weakness.</a> 
In March, nonfarm payrolls surged by 228,000, the Bureau of Labor Statistics reported Friday. The outcome is well above the three-month average of 195,000 and topped economists' forecasts of 135,000. February&#8217;s employment growth was downwardly revised to 117,000. 
Private sector payrolls surged by 209,000, the highest since December 2024. Employment rose in health care, social assistance, and transportation and warehousing. Retail trade also saw job gains, partly due to the return of workers following a strike.
Public sector payrolls surprisingly rose by 19,000, slightly quelling fears of DOGE-related layoffs filtering into the data. 
Meanwhile, the unemployment rate unexpectedly inched higher from 4.1% to 4.2%, defying expectations for no change.
Wage growth broadly matched expectations. Average hourly earnings increased 0.3% from February's pace, as predicted, and rose 3.8% year-over-year, marginally lower than the 3.9% predicted.
<h3 class="wp-block-heading">Market Reactions</h3>
Markets were already in a state of extreme volatility ahead of Friday's jobs report, as tensions escalated between the U.S. and China.
Beijing unveiled a retaliatory 34% tariff on U.S. goods—mirroring the rate announced by President Donald Trump on Wednesday—deepening fears of a full-blown trade war.
Futures tied to the S&amp;P 500—tracked via the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)—slid 2.5% by 8:35 a.m. ET, following a 4.9% rout the previous day.
Nasdaq 100 futures dropped 2.6%, putting the tech-heavy index on course for its sixth consecutive weekly loss. The VIX – also known as &#8220;market fear gauge&#8221; – was up 34%. 
U.S. Treasury yields tumbled as investors fled to safe-haven assets. The yield on the 10-year note fell 15 basis points to 3.88%, marking its lowest level since late September 2024.
Rate cut bets gained traction. Traders now assign a 40% probability to the Federal Reserve lowering interest rates as soon as May, according to the CME FedWatch Tool. Yet, they see June as the most likely month for the next rate cut, applying a 100% likelihood.
Investors now await remarks from Fed Chair Jerome Powell, who will hit the wires at 11:25 a.m. on Friday. 
Read now: 
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/04/44643100/us-stocks-likely-to-open-lower-after-the-worst-selloff-since-2020-tariff-announcement-was-100-smoot-hawley-disguised-as-thoughtful-policy-says-expert">Stocks Set To Continue Crashing After Worst Selloff Since 2020: Tariff Announcement Was &#8216;100% Smoot Hawley Disguised As Thoughtful Policy,&#8217; Says Expert</a></li>
</ul>
Photo: Shutterstock

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

Economics

Federal Reserve

ETFs

Strong Jobs Report Offers Hope — But Will It Be Enough To Counter Tariff Turmoil?

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
<h3 class="wp-block-heading">Bristol-Myers Squibb Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>)</h3>
<ul>
<li>Dividend Yield: 4.29%</li>
<li>Wells Fargo analyst Mohit Bansal maintained an Equal-Weight rating and raised the price target from $60 to $62 on Feb. 7, 2025. This analyst has an accuracy rate of 71%.</li>
<li>Citigroup analyst Andrew Baum maintained a Neutral rating and raised the price target from $60 to $65 on Jan. 28, 2025. This analyst has an accuracy rate of 71%.</li>
<li>Recent News: On March 24, Bristol Myers Squibb received positive CHMP opinion for subcutaneous formulation of Opdiv across multiple solid tumor indications.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0404">latest BMY news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0404"><img loading="lazy" decoding="async" width="906" height="817" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045052/image-43.png" alt="" class="wp-image-857124" style="width:554px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045052/image-43.png 906w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045052/image-43-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045052/image-43-768x693.png 768w" sizes="(max-width: 906px) 100vw, 906px" /></a></figure>
<h3 class="wp-block-heading">DENTSPLY SIRONA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRAY#NASDAQ">XRAY</a>)</h3>
<ul>
<li>Dividend Yield: 4.70%</li>
<li>Morgan Stanley analyst Erin Wright maintained an Overweight rating and cut the price target from $30 to $23 on Dec. 17, 2024. This analyst has an accuracy rate of 75%.</li>
<li>UBS analyst Kevin Caliendo maintained a Buy rating and cut the price target from $35 to $27 on Dec. 3, 2024. This analyst has an accuracy rate of 72%.</li>
<li>Recent News: On March 17, Dentsply Sirona named David Ferguson as Global Business Unit Leader.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest XRAY <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0404">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0404"><img loading="lazy" decoding="async" width="910" height="818" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045120/image-1-13.png" alt="" class="wp-image-857125" style="width:555px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045120/image-1-13.png 910w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045120/image-1-13-300x270.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045120/image-1-13-768x690.png 768w" sizes="(max-width: 910px) 100vw, 910px" /></a></figure>
<h3 class="wp-block-heading">Viatris Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTRS#NASDAQ">VTRS</a>)</h3>
<ul>
<li>Dividend Yield: 5.88%</li>
<li>Piper Sandler analyst David Amsellem reiterated a Neutral rating and raised the price target from $13 to $14 on Dec. 6, 2024. This analyst has an accuracy rate of 73%.</li>
<li>B of A Securities analyst Jason Gerberry downgraded the stock from Neutral to Underperform with a price target of $9 on Oct. 23, 2024. This analyst has an accuracy rate of 62%.</li>
<li>Recent News: Viatris will report first quarter financial results on Thursday, May 8.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest VTRS <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0404">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0404"><img loading="lazy" decoding="async" width="913" height="820" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045307/image-1-14.png" alt="" class="wp-image-857127" style="width:526px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045307/image-1-14.png 913w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045307/image-1-14-300x269.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04045307/image-1-14-768x690.png 768w" sizes="(max-width: 913px) 100vw, 913px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44641655/guess-simulations-plus-and-3-stocks-to-watch-heading-into-friday">Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday</a> </li>
</ul>
Photo via Shutterstock

Dividends

Pre-Market Outlook

Markets

VTRS

XRAY

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields

Baird analyst Craig Kennison downgrades OneWater Marine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEW#NASDAQ">ONEW</a>) from Outperform to Neutral and lowers the price target from $25 to $18.

ONEW

Baird Downgrades OneWater Marine to Neutral, Lowers Price Target to $18

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Barclays analyst Manav Patnaik upgraded the rating for ADT Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADT#NYSE">ADT</a>) from Underweight to Equal-Weight and raised the price target from $7 to $9. ADT shares closed at $8.08 on Thursday. <a href="https://www.benzinga.com/quote/ADT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Rosenblatt analyst Mike Genovese upgraded Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) from Neutral to Buy and lowered the price target from $115 to $85. Coherent shares closed at $53.91 on Thursday. <a href="https://www.benzinga.com/quote/COHR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst James Hardiman upgraded BRP Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOOO#NASDAQ">DOOO</a>) from Sell to Neutral and raised the price target from $27 to $37. BRP shares closed at $35.38 on Thursday. <a href="https://www.benzinga.com/quote/DOOO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Ben Gerlinger upgraded Flagstar Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLG#NYSE">FLG</a>) from Neutral to Buy and raised the price target from $13.5 to $15. Flagstar Financial shares closed at $10.79 on Thursday. <a href="https://www.benzinga.com/quote/flg/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Patrick Cunningham upgraded Eastman Chemical Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) from Neutral to Buy and lowered the price target from $105 to $101. Eastman Chemical shares closed at $79.98 on Thursday.  <a href="https://www.benzinga.com/quote/emn/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying ADT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="594" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04081750/image-46-1024x594.png" alt="" class="wp-image-857450" style="width:547px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04081750/image-46-1024x594.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04081750/image-46-300x174.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04081750/image-46-768x445.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04081750/image-46.png 1092w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44641655/guess-simulations-plus-and-3-stocks-to-watch-heading-into-friday">Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday</a> </li>
</ul>
Photo via Shutterstock

Upgrades

COHR

DOOO

EDAP

This Eastman Chemical Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Baird analyst Craig Kennison downgrades MasterCraft Boat Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCFT#NASDAQ">MCFT</a>) from Outperform to Neutral and lowers the price target from $26 to $20.

MCFT

Baird Downgrades MasterCraft Boat Hldgs to Neutral, Lowers Price Target to $20

WIIM

PAMT

PAMT CORP shares are trading higher after the company announced it will repurchase 435K shares of common stock.

Citigroup analyst Spiro Dounis initiates coverage on TC Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TRP#TSX">TRP</a>) with a Neutral rating and announces Price Target of C$75.

TSX:TRP

Citigroup Initiates Coverage On TC Energy with Neutral Rating, Announces Price Target of C$75

LNZA

LanzaTech Global shares are trading lower. The company announced it received a $0.02 per share takeover offer from Carbon Direct Capital.

Baird analyst Craig Kennison downgrades Malibu Boats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBUU#NASDAQ">MBUU</a>) from Outperform to Neutral and lowers the price target from $50 to $32.

MBUU

Baird Downgrades Malibu Boats to Neutral, Lowers Price Target to $32

Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) will release its first-quarter earnings results after the <a href="https://www.benzinga.com/quote/LEVI/earnings">closing bell on Monday, April 7</a>.
Analysts expect the company to report quarterly earnings at 28 cents per share. That&#8217;s up from 26 cents per share in the year-ago period. According to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro</a>, Levi Strauss projects quarterly revenue at $1.54 billion, compared to $1.56 billion a year earlier.
On Wednesday, Telsey Advisory Group analyst Dana Telsey maintained Levi Strauss with an Outperform rating and maintained a $23 price target.
With the recent buzz around Levi Strauss, some investors may be eyeing potential gains from the company's dividends. Currently, Levi Strauss offers an annual dividend yield of 3.60% and a quarterly dividend of 13 cents per share (52 cents a year).  
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $166,623 or around 11,539 shares. For a more modest $100 per month or $1,200 per year, you would need $33,328 or around 2,308 shares.
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($0.52 in this case). So, $6,000 / $0.52 = 11,539 ($500 per month), and $1,200 / $0.52 = 2,308 shares ($100 per month).
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock&#8217;s current price.
For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
LEVI Price Action: Shares of Levi Strauss fell 13.7% to close at $14.44 on Thursday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44626468/top-3-risk-off-stocks-that-are-ticking-portfolio-bombs">Top 3 Risk Off Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>
Image: Shutterstock

Earnings

Long Ideas

LEVI

How To Earn $500 A Month From Levi Strauss Stock Ahead Of Q1 Earnings

On Friday, AerCap Holdings N.V. (AER) announced key first-quarter 2025 <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n44643706/aercap-leased-purchased-and-sold-203-assets-in-the-first-quarter-2025" rel="noreferrer noopener">financial and operational performance updates</a>.
Asset Transactions: The company signed 112 lease agreements, including four widebody and 47 narrowbody aircraft, 42 engines and 19 helicopters. It also completed 49 acquisitions (13 aircraft, 35 engines, one helicopter) and finalized 42 sales (29 aircraft, 11 engines, two helicopters). ​
Financial Activities: AerCap secured financing transactions totaling approximately $1.5 billion and repurchased 5.7 million shares at an average price of $97.93 per share, amounting to $558 million.​
Dividend Declaration: The company declared a quarterly cash dividend of $0.27 per share.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/25/03/44431541/malaysia-aviation-group-orders-30-boeing-737-max-jets-secures-option-for-30-more-amid-rising-southeast-asia-demand" rel="noreferrer noopener">Malaysia Aviation Group Orders 30 Boeing 737 MAX Jets, Secures Option For 30 More Amid Rising Southeast Asia Demand</a>
Last month, amid escalating trade tensions, AerCap CEO Aengus Kelly <a href="https://www.benzinga.com/markets/25/03/44296119/boeing-787-prices-could-jump-by-40m-in-worst-case-scenario-amid-trump-tariffs-warns-aercap-chief" target="_blank" rel="noreferrer noopener">warned</a> that tariffs could raise Boeing 787 costs by $40 million, potentially benefiting Airbus, which is better positioned to withstand tariff impacts.
Price Action: AER shares are trading lower by 2.91% at $95.78 premarket on the last check on Friday.
Photo: Shutterstock

AerCap Concludes Q1 With Impressive Fleet Transactions And Financing

HC Wainwright &amp; Co. analyst Mitchell Kapoor reiterates Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) with a Neutral and maintains $75 price target.

Reiteration

SRPT

HC Wainwright & Co. Reiterates Neutral on Sarepta Therapeutics, Maintains $75 Price Target

NMTC

NeuroOne Medical Technologies shares are trading lower following its $8 million stock offering.

Baird analyst Craig Kennison downgrades LCI Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LCII#NYSE">LCII</a>) from Outperform to Neutral and lowers the price target from $130 to $100.

LCII

Baird Downgrades LCI Industries to Neutral, Lowers Price Target to $100

Press Releases

Xos, Inc. Announces Second Quarter 2024 Earnings Release Date and Conference Call

Xos, Inc. Reschedules Second Quarter 2024 Earnings Release Date and Conference Call

Xos, Inc. delivers strong unit delivery, sales growth and promising operating profit performance in the second quarter of 2024

General

Xos, Inc. Unveils 2025 Xos SV Stepvan, Offering Greater Flexibility for Fleets

Xos, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call

Xos, Inc. delivers strong unit delivery and promising gross profit performance in the third quarter of 2024

Xos, Inc. Powers Crown Linen Service, Inc.'s Energy Initiatives with Battery-Electric Stepvans

Xos, Inc. Announces Major Milestone: Xos Hub Listed on Federal GSA Schedule

Xos, Inc. Announces Fourth Quarter 2024 Earnings Release Date and Conference Call

Xos, Inc. Reports Record-Breaking 2024 with Growing Unit Deliveries and Highest-Ever Gross Profit

Comments

Xos

ニュース

最新ニュース Xos (NASDAQ:XOS) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル